ClinicalTrials.Veeva

Menu

Dimensional Changes of Peri-implant Tissue in Immediate Implants With Individualized Healing Abutments

U

Universitat Internacional de Catalunya

Status

Enrolling

Conditions

Wound Heal
Immediate Dental Implant
Dental Implant

Treatments

Device: Individualized healing abutment
Device: Standard healing abutment

Study type

Interventional

Funder types

Other

Identifiers

NCT06455436
PER-ECL-2023-10

Details and patient eligibility

About

The loss of a tooth leads to a series of biological changes in the tissues, resulting in bone resorption and gingival collapse. To avoid these problems, it has been proposed to place immediate post-extraction implants, allowing a reduction in treatment time and the number of surgeries, as well as better maintenance of the tissues. This technique can be performed with standard abutments after implant placement or, more recently, the use of temporary abutments has been proposed.

Full description

Objective: To check if custom healing abutments manufactured using CAD/CAM technique in immediate implants promote greater dimensional stability of the peri-implant tissue compared to standard healing abutments.

Methods: After the extraction, an immediate Klockner Vega+ implant will be placed and the gap will be filled with a bone substitute (Cerabone, Botiss). The patient will then be randomized to the control group (standard healing abutment) or the test group (custom healing abutment using CAD/CAM technique). In the latter case, a peripheral seal is achieved, allowing for wound closure and stabilization of the clot with the same shape as the crown in its transmucosal part.

Enrollment

32 estimated patients

Sex

All

Ages

25+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult patient ( 25 years old).
  • Need for extraction of an irrational tooth to be treated in the molar/premolar position of the upper/lower arch.
  • Presence of 2mm of keratinized gingiva.
  • Bone dehiscence in the alveolar walls of 2 mm. 2 mm.
  • Adequate amount of bone in the interradicular septum to stabilize the implant (minimum height 10 mm, minimum width 4 mm at the base of the septum).
  • Plaque index (FMSPI, full mouth score plaque index) < 10%.
  • Non-smokers or smokers of less than 10 cigarettes per day.
  • Absence of systemic diseases that contraindicate implant surgery.

Exclusion criteria

  • Presence of alveoli with dehiscence >2mm.
  • Presence of adjacent implants.
  • < 2mm of keratinized gingiva.
  • Presence of active infection (fistula, suppuration) at the extraction site.
  • Presence of apical granuloma >2mm in diameter in the root(s) of the tooth or teeth to be extracted.
  • Residual bone apical to the extraction insufficient to anchor the implant.
  • Pregnant or lactating women.
  • Severe cognitive or psychiatric disorders.
  • Compromised general health status ( ASA IV).
  • Use of drugs that alter bone metabolism and healing.
  • Absence of manual primary stability of the implant
  • Bone dehiscence or fenestration after implant placement (manual rotation).
  • Gap 2mm between the implant and the vestibular bone wall.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

32 participants in 2 patient groups

Control group
Active Comparator group
Description:
Will receive standard healing abutments
Treatment:
Device: Standard healing abutment
Individualized healing abutment group
Experimental group
Description:
Will receive individualized healing abutments
Treatment:
Device: Individualized healing abutment

Trial contacts and locations

1

Loading...

Central trial contact

Javi Vilarrasa, MSc; Nicolas Padros, DDs

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems